Mia Rodziewicz
105 posts
Mia Rodziewicz
@MiaRodziewicz
Specialist Registrar in Rheumatology | MRC Clinical Research Fellow | Lupus, APS & therapeutics 🦋🩺 @OfficialUoM @UoMMskResearch 👩⚕️| Own views | she/her
Katılım Aralık 2022
359 Takip Edilen311 Takipçiler
Español
🚨 Delighted to share that I’ll be starting a new academic position at @OfficialUoM in April 2025, working with @ManchesterBRC!
I’ll be focusing on SSc and connective tissue diseases, contributing to innovative research in precision medicine and major organ involvement🙌
English
Excellent presentation from @sshoopworrall on involving patients to interpret findings from complex statistical modelling at #UKRIME
English
Engaging with patients in PPIE at our Lupus workshop in Kisumu today was an incredibly rewarding experience!
English
Mia Rodziewicz retweetledi
Now it's the turn of #rheumatology #HealthcareProfessionals in the #UK to share your views and current practice on #ClinicLetter writing
This @RheumatologyUK funded survey is open to all #doctors #nurses #AHPs #pharmacists
👀bit.ly/W2Phcpsurvey
Please share!
Dr Rebecca Goulding@RGouldingUoM
Rheumatology MDT members: Do you conduct #Rheumatology outpatient consultations in the UK NHS/HSC? If so, we want to know what you think about writing clinic letters directly to patients. To complete our survey, or for more information, please visit: bit.ly/W2Phcpsurvey
English
@georgedemirakos Amongst other topics. Check out the scope 👆😉
English
🫁 Looking forward to answering some clinical questions current guidelines don't cover
🔵 Lots of work ahead!
BSR@RheumatologyUK
📝Just published: guideline scope for the new BSR guideline for systemic autoimmune rheumatic disease-related interstitial lung disease. Learn why our members proposed this guideline and access the scope here: bit.ly/45r6DBV @ILDIPFDoc_NI @jrironside @MiaRodziewicz
English
Mia Rodziewicz retweetledi
Efficacy of rituximab in neuropsychiatric #SLE : data from the BILAG biological register.
#EULAR2024
MS
Română
Classifying ANA-positive patients through clinico-biological patterns (including IFN-I expression) may be more efficient than classical disease classifications. #EULAR2024
MS
English
Important work from @sarahdyball1
❕Around half of SLE patients demonstrating a clinical improvement failed actually FEEL better psychologically
Rudi Shukla@rudi_shukla
Chairing and presenting a talk at #EULAR2024! Great work by @sarahdyball1 highlighting discordance between clinical and pt reported outcomes from BILAG-BR! @UoMMskResearch @EMEUNET @Lupusdoc
English
Great presentation from @RheumJArn on novel reclassification of ANA+ RMD patients
❔could this be used to explain heterogeneity in clinical response to treatment in future trials❔
English
@TroldborgAnne Oh wow, and talking about such an old drug too 😅
English
@MiaRodziewicz Wonderful talk, Mia. Congratulations! - And just teasing, but very "into the future" #2025🤣
English
Day 1 at #EULAR2025
🚨 Catch me presenting on real-world outcomes of NPSLE treated with rituximab 16.50-17.00hrs in C8
🔵Also looking forward to hearing CAR-T and novel agent trial updates
English
@TroldborgAnne @sarahdyball1 There has been just one RCT in NPSLE (cyclo), would love to see one of rituximab but not sure it will happen! 👀
English
@sarahdyball1 @MiaRodziewicz Yes, what a fantastic registry! I agree, that these are observational data (with the limitations that come along with that). However, it's really large, real-life data, which I think is just what we need!
English
Fantastic presentation from @MiaRodziewicz using BILAG-BR data:
⭐️NPSLE had higher damage / disease activity
⭐️ NPSLE more likely to have APS ab
⭐️ RTX appears effective in NPSLE (no trials)
English
Mia Rodziewicz retweetledi
✅ TODAY is the official start of #EULAR2024 ✨ with the convergence of 12k+ #Rheumatology specialists & researchers from ALL over the world. The full program of this @eular_org event is truly AMAZING, and for #Lupus there will be 33 oral presentations and almost 200 posters 👍
English
Mia Rodziewicz retweetledi
💥Significant proportion of CTD patients are excluded from Ph3 clinical trials
💥Classification criteria may take several years to be adopted into trial protocols
💥Stringent trial eligibility may lead to poor generalisability for real-world patients
👇
sciencedirect.com/science/articl…
English
Evidence that unconscious bias affects the care we give
🇺🇸 Don't think this is limited to the USA
🗣️ So important to reflect on our own personal biases but also the social structures we operate within
Science Magazine@ScienceMagazine
Military physicians give patients whose military rank is higher better treatment than those who rank lower, according to a new Science study involving 1.5 million patient encounters. Learn more ⬇️ 📄: scim.ag/71M #SciencePerspective: scim.ag/71N
English
@MareticSanja You too Sanja! Thanks so much again for such a much needed and thought provoking talk 🙏
English
Thanks for the thought provoking speaker suggestion @lizzymacphie
English